Danaher Corporation
As of Fiscal Year 2025 (ended December 31, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total revenue (FY2025) | $24.6 billion, up 3.0% year-over-year (2.0% non-GAAP core revenue growth) |
| Net income (FY2025) | $3.6 billion, down from $3.9 billion in FY2024 |
| Diluted EPS (FY2025) | $5.03 GAAP; $7.80 non-GAAP adjusted diluted EPS, up 4.5% year-over-year |
| Consolidated operating profit (FY2025) | $4.69 billion |
| Operating cash flow / free cash flow (FY2025) | $6.4 billion operating cash flow; $5.3 billion free cash flow |
| Largest segment (FY2025) | Diagnostics, at $10.0 billion of revenue (about 41% of the total) and $2.7 billion of segment operating profit |
| Employees (as of December 31, 2025) | approximately 60,000 associates worldwide |
Sources: Segment revenue, segment operating profit, and consolidated results are from Danaher's Q4/Full Year 2025 earnings release (SEC Form 8-K Exhibit 99.1, reported January 28, 2026) and FY2025 Form 10-K. Danaher completed the separation (spin-off) of its Environmental & Applied Solutions business as Veralto Corporation in September 2023; FY2021 and FY2022 total revenue figures below are as originally reported at the time (including the businesses that became Veralto), while FY2023-FY2025 reflect continuing operations only, so the FY2022-to-FY2023 decline in the revenue chart reflects that divestiture, not underlying business contraction. No specific third-party market-share estimate for Danaher's diversified life-sciences/diagnostics businesses was found that met sourcing standards, so no market-share figure is included.